Search

everythinglearnresearchcommunity

for

Search:↓

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Histone modification is key in treating chronic inflammatory skin diseases.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Non-immune factors play a significant role in alopecia areata.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Vitamin A affects hair loss and immune response in alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Aged individuals heal wounds less effectively due to specific immune cell issues.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

TNF-alpha inhibitors can cause various immune-related skin issues.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

New therapies are being developed that target integrin pathways to treat various diseases.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.